Study finds increased risk of POTS after SARS-CoV-2 infection or COVID vaccination Coronavirus Disease COVID SARSCoV2 tachycardia NatureCVR karolinskainst UBuffalo
By Pooja Toshniwal PahariaDec 20 2022Reviewed by Benedette Cuffari, M.Sc. In a recent News & Views article published in the journal Nature Cardiovascular Research, researchers report the frequencies of novel postural orthostatic tachycardia syndrome -related diagnoses including POTS, fatigue, dysautonomia, Ehlers–Danlos syndrome, and mast cell diseases, prior to and after severe acute respiratory syndrome coronavirus 2 infection and coronavirus disease 2019 vaccination.
POTS is a common autonomic nervous system disorder that is characterized by tachycardia or an increase of 30 beats/minute or more during 10 minutes of being in the standing position and orthostatic intolerance symptoms. POTS symptomatology includes palpitations, pre-syncope, generalized weakness, light-headedness, nausea, and headache that lasts for more than three months.
About the study Electronic health records data from 284,592 COVID-19 vaccinees and 12,460 SARS-CoV-2-positive individuals were analyzed. The sample population of the study comprised 300,000 COVID-19 vaccinees from Los Angeles County in the United States of America. The assimilation of all new-onset POTS-related diagnoses together yielded marginally lower odds. Among SARS-CoV-2-positive individuals, the pre-COVID-19 incidence of new-onset POTS was 2% as compared to 3% post-COVID-19. Thus, the risk of developing POTS was greater among individuals with SARS-CoV-2 infections as compared to those after COVID-19 vaccination.
Nevertheless, the rate of new POTS diagnoses was more than five-fold greater post-COVID-19 as compared to that following vaccinations. This finding underpins the importance of vaccinations and can be referenced by healthcare professionals to reduce COVID-19 vaccine reluctance among the public.
Brasil Últimas Notícias, Brasil Manchetes
Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.
Study demonstrates robust antibody response elicited by trivalent protein subunit vaccine against SARS-CoV-2Study demonstrates robust antibody response elicited by trivalent protein subunit vaccine against SARS-CoV-2 biorxivpreprint PittHealthSci antibody antibodies vaccine vaccination SARSCoV2 COVID19 covid coronavirus
Consulte Mais informação »
Milk antibodies against SARS-CoV-2 after booster vaccination and breakthrough infectionMilk antibodies against SARS-CoV-2 after booster vaccination and breakthrough infection medrxivpreprint UCSF SARSCoV2 COVID19 Booster Vaccine Vaccination
Consulte Mais informação »
What is the impact of cholesterol on SARS-CoV-2 Spike protein-mediated membrane fusion?Researchers assessed the impact of ceramide (CER) and cholesterol (CHOL) on membrane fusion mediated by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein.
Consulte Mais informação »
The potential effects of receiving 2 SARS-CoV-2 vaccine doses on household transmission in EnglandThe potential effects of receiving 2 SARS-CoV-2 vaccine doses on household transmission in England CDCgov ucl SARSCoV2 vaccine vaccination transmission covid coronavirus covid
Consulte Mais informação »
SARS-CoV-2 structural proteins trigger periodontal fibrosisResearchers examined the pathological impacts of the structural components of SARS-CoV-2 on human periodontal cells and tissue to understand the association between coronavirus disease 2019 (COVID-19) and deteriorating oral health.
Consulte Mais informação »
Study finds several flavor/fragrance compositions that inhibit vRBD-hACE2 bindingStudy finds several flavor/fragrance compositions that inhibit vRBD-hACE2 binding PLOSONE flavor fragrance compounds chemicals COVID19 coronavirus covid ACE2
Consulte Mais informação »